Journal of Hepatology
Volume 48 , Pages S58-S67 , 2008

Hot topics in liver transplantation: Organ allocation – extended criteria donor – living donor liver transplantation

  • Beat Müllhaupt

      Affiliations

    • Swiss HPB (Hepato-Pancreato-Biliary) Center, Department of Gastroenterology and Hepatology, University Hospital Zürich, Ramistrasse 100, 8091 Zürich, Switzerland
    • Corresponding Author InformationCorresponding author. Fax: +41 1 255 45 98.
    • ,
  • Dimitrios Dimitroulis

      Affiliations

    • Swiss HPB (Hepato-Pancreato-Biliary) Center, Department of Surgery, University Hospital Zürich, Ramistrasse 100, 8091 Zürich, Switzerland
    • ,
  • J. Tilman Gerlach

      Affiliations

    • Swiss HPB (Hepato-Pancreato-Biliary) Center, Department of Gastroenterology and Hepatology, University Hospital Zürich, Ramistrasse 100, 8091 Zürich, Switzerland
    • ,
  • Pierre-Alain Clavien

      Affiliations

    • Swiss HPB (Hepato-Pancreato-Biliary) Center, Department of Surgery, University Hospital Zürich, Ramistrasse 100, 8091 Zürich, Switzerland

References 

  1. Everson GT. MELD: the answer or just more questions?. Gastroenterology. 2003;124:251–254
  2. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg. 1997;3:628–637
  3. Freeman RB, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl. 2000;6:543–552
  4. Kadry Z, Renner EL, Clavien PA. Transplant legislation: ethical and practical issues in liver allocation – the case of Switzerland. Liver Transpl. 2001;7:658–660
  5. Coombes JM, Trotter JF. Development of the allocation system for deceased donor liver transplantation. Clin Med Res. 2005;3:87–92
  6. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871
  7. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470
  8. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–96
  9. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001;7:567–580
  10. Freeman RB. MELD: the holy grail of organ allocation?. J Hepatol. 2005;42:16–20
  11. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl. 2004;10:7–15
  12. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant. 2005;5:307–313
  13. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology. 2004;127:S261–S267
  14. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl. 2004;10:995–1000
  15. Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl. 2007;13:523–529
  16. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41:32–39
  17. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802–810
  18. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl. 2005;11:336–343
  19. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660
  20. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet. 2006;367:225–232
  21. Ioannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl. 2006;12:1594–1606
  22. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049–1061
  23. Clavien PA. How far can we go with marginal donors?. J Hepatol. 2006;45:483–484
  24. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003;9:651–663
  25. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology. 2002;36:202–210
  26. Deschenes M, Forbes C, Tchervenkov J, Barkun J, Metrakos P, Tector J, et al. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg. 1999;5:357–361
  27. Merion R, Goodrich NP, Feng S. How can we define expanded criteria for liver donors?. J Hepatol. 2006;45:484–488
  28. Briceno J, Lopez-Cillero P, Rufian S, Diaz-Iglesias C, Solorzano G, Padillo J, et al. Impact of marginal quality donors on the outcome of liver transplantation. Transplant Proc. 1997;29:477–480
  29. Grande L, Matus D, Rimola A, Manyalic M, Cabrer C, Garcia-Valdecasas JC, et al. Expanded liver donor age over 60years for hepatic transplantation. Clin Transpl. 1998;297–301
  30. Karatzas T, Olson L, Ciancio G, Burke GW, Spires G, Cravero L, et al. Expanded liver donor age over 60years for hepatic transplantation. Transplant Proc. 1997;29:2830–2831
  31. Oh CK, Sanfey HA, Pelletier SJ, Sawyer RG, McCullough CS, Pruett TL. Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant. 2000;14:386–390
  32. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation. 1990;49:377–381
  33. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–790
  34. Markmann J, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation. 2001;72:1113–1122
  35. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Fung JJ, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc. 1995;27:2898
  36. D’Alessandro A, Hoffmann RM, Knechtle SJ, Eckhoff DE, Love RB, Kalayoglu M, et al. Successful extra-renal transplantation from non-heart-beating donors. Transplantation. 1995;59:977–982
  37. Weber M, Dindo D, Demartines N, Ambuhl PM, Clavien PA. Kidney transplantation from donors without a heartbeat. N Engl J Med. 2002;347:248–255
  38. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27:2893–2894
  39. Muiesan P, Girlanda R, Jassem W, Melendez HV, O‘Grady J, Bowles M, et al. Single-center experience with liver transplantation from controlled non-heart-beating donors: a viable source of grafts. Ann Surg. 2005;242:732–738
  40. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004;239:87–92
  41. Folley D, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the Universiy of Winsconcin experience with liver transplantation. Ann Surg. 2005;242:716–723
  42. Manzarbeitia C, Ortiz JA, Jeon H, Rothstein KD, Martinez O, Araya VR, et al. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation. 2004;78:211–215
  43. Dutkowski P, Graf R, Clavien PA. Rescue of the cold preserved rat liver by hypothermic oxygenated machine perfusion. Am J Transplant. 2006;6:903–912
  44. Donnelly K, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non alcoholic fatty liver disease. J Clin Invest. 2005;115:1343
  45. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 1995;67:101
  46. Adam R, Reynes M, Johann M, Morino M, Astarcioglu I, Kafetzis I, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc. 1991;23:1538–1540
  47. Dawwas MF, David C, Barber KM, Watson CJ, Neuberger J, Gimson AE. Developing a liver transplantation donor risk index in a national registy. Hepatology. 2007;46:235A
  48. Imber CJ, St Peter SD, Lopez I, Guiver L, Friend PJ. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl. 2002;8:545–549
  49. Nocito A, El-Bardy AM, Clavien PA. When is steatosis too much for transplantation?. J Hepatol. 2006;45:494–499
  50. Garcia Urena MA, Colina Ruiz-Delgado F, Moreno Gonzalez E, Jimenez Romero C, Garcia Garcia I, Loinzaz Segurola C, et al. Hepatic steatosis in liver transplant donors: common feature of donor population?. World J Surg. 1998;22:837–844
  51. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994;20:829–838
  52. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64:248–251
  53. Hayashi M, Fujii K, Kiuchi T, Uryuhara K, Kasahara M, Takatsuki M, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transplant Proc. 1999;31:403
  54. Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, et al. Frozen section evaluation of donor livers before transplantation. Transplantation. 1993;56:1403–1409
  55. Briceno J, Padillo J, Rufian S, Solorzano G, Pera C. Assignment of steatotic livers by the Mayo model for end-stage liver disease. Trans Int. 2005;18:577
  56. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246:940–946discussion 946–948
  57. Wilms C, Walter J, Kaptein M, Mueller L, Lenk C, Sterneck M, et al. Long-term outcome of split liver transplantation using right extended grafts in adulthood: a matched pair analysis. Ann Surg. 2006;244:865–872discussion 872–873
  58. Azoulay D, Castaing D, Adam R, Savier E, Delvart V, Karam V, et al. Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg. 2001;233:565–574
  59. Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation. 2002;74:522–526
  60. Piratvisuth T, Tredger JM, Hayllar KA, Williams R. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg. 1995;1:296–301
  61. Ploeg RJ, D’Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation–a multivariate analysis. Transplantation. 1993;55:807–813
  62. Amin MG, Wolf MP, TenBrook JA, Freeman RB, Cheng SJ, Pratt DS, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 2004;10:1468–1475
  63. Strong R, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med. 1990;322:1505–1507
  64. Broelsch C, Whitington PF, Emond JC, Heffron TG, Thistlethwaite JR, Stevens L, et al. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg. 1991;214:428–437
  65. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med. 2002;346:1074–1082
  66. Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant. 2007;7:1624–1628
  67. Trotter JF, Campsen J, Bak T, Wachs M, Forman L, Everson G, et al. Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant. 2006;6:1882–1889
  68. Valentin-Gamazo C, Malago M, Karliova M, Lutz JT, Frilling A, Nadalin S, et al. Experience after the evaluation of 700 potential donors for living donor liver transplantation in a single center. Liver Transpl. 2004;10:1087–1096
  69. Chisuwa H, Hashikura Y, Mita A, Miyagawa S, Terada M, Ikegami T, et al. Living liver donation: preoperative assessment, anatomic considerations, and long-term outcome. Transplantation. 2003;75:1670–1676
  70. Morimoto T, Ichimiya M, Tanaka A, Ikai I, Yamamoto Y, Nakamura Y, et al. Guidelines for donor selection and an overview of the donor operation in living related liver transplantation. Transpl Int. 1996;9:208–213
  71. Middleton PF, Duffield M, Lynch SV, Padbury RT, House T, Stanton P, et al. Living donor liver transplantation – adult donor outcomes: a systematic review. Liver Transpl. 2006;12:24–30
  72. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111:518–526
  73. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213
  74. Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, et al. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation. 2006;81:1373–1385
  75. Patel S, Orloff M, Tsoulfas G, Kashyap R, Jain A, Bozorgzadeh A, et al. Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant. 2007;7:2344–2349
  76. Trotter JF, Hill-Callahan MM, Gillespie BW, Nielsen CA, Saab S, Shrestha R, et al. Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation. 2007;83:1506–1508
  77. Marcos A, Fisher RA, Ham JM, Olzinski AT, Shiffman ML, Sanyal AJ, et al. Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation. 2000;69:2410–2415
  78. Testa G, Malago M, Nadalin S, Hertl M, Lang H, Frilling A, et al. Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl. 2002;8:340–346
  79. Kam I. Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl. 2002;8:347–349
  80. Tan HP, Patel-Tom K, Marcos A. Adult living donor liver transplantation: who is the ideal donor and recipient?. J Hepatol. 2005;43:13–17
  81. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242:314–323discussion 323–315
  82. Abt PL, Mange KC, Olthoff KM, Markmann JF, Reddy KR, Shaked A. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant. 2004;4:1302–1307
  83. Thuluvath PJ, Yoo HY. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl. 2004;10:1263–1268
  84. Shiffman ML, Saab S, Feng S, Abecassis MI, Tzakis AG, Goodrich NP, et al. Liver and intestine transplantation in the United States, 1995–2004. Am J Transplant. 2006;6:1170–1187
  85. Shah SA, Levy GA, Greig PD, Smith R, McGilvray ID, Lilly LB, et al. Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing. Am J Transplant. 2007;7:998–1002
  86. Berg CL, Gillespie BW, Merion RM, Brown RS, Abecassis MM, Trotter JF, et al. Improvement in survival associated with adult-to-adults living donor liver transplantation. Gastroenterology. 2007;133:1806–1813
  87. Liu CL, Lo CM, Fan ST. What is the best technique for right hemiliver living donor liver transplantation? With or without the middle hepatic vein? Duct-to-duct biliary anastomosis or Roux-en-Y hepaticojejunostomy?. J Hepatol. 2005;43:17–22
  88. Gondolesi GE, Varotti G, Florman SS, Munoz L, Fishbein TM, Emre SH, et al. Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation. 2004;77:1842–1848
  89. Liu CL, Lo CM, Chan SC, Fan ST. Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage. Transplantation. 2004;77:726–732
  90. Shah SA, Grant DR, McGilvray ID, Greig PD, Selzner M, Lilly LB, et al. Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center. Am J Transplant. 2007;7:161–167
  91. Merion R, Shearon TH, Berg CL, Everhart JE, Abecasis R, Shaked A, et al. Hospitalisations rates before and after adult-to-adult living donor or deceased donor liver transplantation. Hepatology. 2007;46:234A
  92. Foster R, Zimmerman M, Trotter JF. Expanding donor options: marginal, living, and split donors. Clin Liver Dis. 2007;11:417–429
  93. Sugawara Y, Makuuchi M. Should living donor liver transplantation be offered to patients with hepatitis C virus cirrhosis?. J Hepatol. 2005;42:472–475
  94. Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, et al. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007;13:122–129

☆ The authors declare that they do not have anything to disclose regarding industry funding or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00060-3

doi: 10.1016/j.jhep.2008.01.013

Journal of Hepatology
Volume 48 , Pages S58-S67 , 2008

Article Tools